Evidence Archives

MINDACT Supplementary Appendix NEJM 2016
Gallery
MINDACT Supplementary Appendix NEJM 2016

Adjuvant, Evidence, MammaPrint, MINDACT

MINDACT Supplementary Appendix NEJM 2016

SUPPLEMENTARY APPENDIX: This appendix has been provided by the authors Read More

kevin2024-03-25T09:18:44-07:00August 15th, 2016|Adjuvant, Evidence, MammaPrint, MINDACT|

Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures
Gallery
Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures

BluePrint, Evidence, NBRST, Neoadjuvant

Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures

PUBLICATION: Ann Surg Oncol (2016) 23: 3317. https://doi.org/10.1245/s10434-016-5329-6. AUTHORS: Peter Read More

kevin2024-03-25T09:19:31-07:00July 6th, 2016|BluePrint, Evidence, NBRST, Neoadjuvant|

Breast Cancer: Determining the Genetic Profile from Ultrasound-Guided Percutaneous Biopsy Specimens Obtained During Diagnostic Workups
Gallery
Breast Cancer: Determining the Genetic Profile from Ultrasound-Guided Percutaneous Biopsy Specimens Obtained During Diagnostic Workups

Evidence, MammaPrint, Other

Breast Cancer: Determining the Genetic Profile from Ultrasound-Guided Percutaneous Biopsy Specimens Obtained During Diagnostic Workups

PUBLICATION: Radiología (English Edition) Volume 58, Issue 3, May–June 2016, Read More

kevin2024-03-25T09:20:15-07:00June 14th, 2016|Evidence, MammaPrint, Other|

Cáncer de Mama: Determinación del Perfil Genético a Partir de la Biopsia Percutánea Ecoguiada Diagnóstica
Gallery
Cáncer de Mama: Determinación del Perfil Genético a Partir de la Biopsia Percutánea Ecoguiada Diagnóstica

Evidence, MammaPrint, Other

Cáncer de Mama: Determinación del Perfil Genético a Partir de la Biopsia Percutánea Ecoguiada Diagnóstica

PUBLICATION: Radiología; Vol. 58. Issue 3. pages 214-220 (May-June 2016) Read More

kevin2024-03-25T09:20:44-07:00June 1st, 2016|Evidence, MammaPrint, Other|

Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
Gallery
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

BluePrint, Evidence, NBRST, Neoadjuvant

Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

PUBLICATION: Ann Surg Oncol (2016) 23: 1522. https://doi.org/10.1245/s10434-015-5030-1. AUTHORS: Paul Read More

kevin2024-03-25T09:21:21-07:00May 1st, 2016|BluePrint, Evidence, NBRST, Neoadjuvant|

Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics
Gallery
Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

Evidence, MammaPrint, Other, Validation

Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

PUBLICATION: Breast Cancer Res Treat (2016) 156: 279. https://doi.org/10.1007/s10549-016-3764-5 AUTHORS: Read More

kevin2024-03-25T09:21:49-07:00March 22nd, 2016|Evidence, MammaPrint, Other, Validation|

Molecular Subtyping Improves Diagnostic Stratification of Patients with Primary Breast Cancer into Prognostically-Defined Risk Groups
Gallery
Molecular Subtyping Improves Diagnostic Stratification of Patients with Primary Breast Cancer into Prognostically-Defined Risk Groups

BluePrint, Evidence, Other

Molecular Subtyping Improves Diagnostic Stratification of Patients with Primary Breast Cancer into Prognostically-Defined Risk Groups

PUBLICATION: Breast Cancer Res Treat (2015) 154: 81. https://doi.org/10.1007/s10549-015-3587-9. AUTHORS: Read More

kevin2024-03-25T09:23:03-07:00November 1st, 2015|BluePrint, Evidence, Other|

Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients
Gallery
Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients

Evidence, MammaPrint, Other, Racial Disparities

Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients

PUBLICATION: Breast Care 2015;10:118-122 https://doi.org/10.1159/000376562. AUTHORS: Shimizu H., Horimoto Y., Read More

kevin2024-03-25T09:25:03-07:00March 1st, 2015|Evidence, MammaPrint, Other, Racial Disparities|

Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis
Gallery
Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

Adjuvant, Evidence, MammaPrint

Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

PUBLICATION: Breast Cancer Res Treat (2014) 148: 599. https://doi.org/10.1007/s10549-014-3188-z. AUTHORS: Read More

kevin2024-03-25T09:27:24-07:00November 24th, 2014|Adjuvant, Evidence, MammaPrint|

Genomic Profile of Breast Cancer: Cost-Effectiveness Analysis from the Spanish National Healthcare System Perspective
Gallery
Genomic Profile of Breast Cancer: Cost-Effectiveness Analysis from the Spanish National Healthcare System Perspective

Evidence, Healthcare Economics, MammaPrint, Other

Genomic Profile of Breast Cancer: Cost-Effectiveness Analysis from the Spanish National Healthcare System Perspective

PUBLICATION: Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):889-99. doi: 10.1586/14737167.2014.957185. Read More

kevin2024-03-25T11:22:23-07:00September 12th, 2014|Evidence, Healthcare Economics, MammaPrint, Other|